Pharmaceutical Giant Pfizer said on Thursday that it is preparing to ramp up production of its Covid-19. It comes a day after the US Federal Administration amended a pause on administering injections of the Johnson & Johnson vaccine over health concerns. In a Twitter post, Pfizer CEO confirmed the news.
Pfizer CEO Albert Bourla said that the company could exceed its production by 10% than previously agreed to. Now the limit of the vaccine doses will increase to 220 million, and it is projected to be administered by the end of May. He said that Pfizer will be able to supply its full quota of 300 million doses to the US health departments by the end of July. The timeline is two weeks ahead of what the pharmaceutical giant’s officials predicted.
“We believe there’s enough vaccine in the system — Moderna and Pfizer — for all Americans who want to get vaccinated by May 31 to do so,” said Jeff Zients, the White House’s COVID-19 response coordinator. This came after Jonhson & Johnson said that the health and the safety of people who use their vaccine is its number one priority.